Matches in SemOpenAlex for { <https://semopenalex.org/work/W2016168519> ?p ?o ?g. }
- W2016168519 endingPage "38" @default.
- W2016168519 startingPage "31" @default.
- W2016168519 abstract "Cancer is one of largest killers in the world and defeating it represents one of the most important challenges in Medicine today. For instance, annually, around 1.38 million women are diagnosed worldwide with breast cancer and approximately 0.25 million men worldwide are diagnosed with prostate and testicular cancer. Patients with oestrogen receptor-positive breast cancer receiving adjuvent Tamoxifen for five years have on average a 50% reduction in disease recurrence but only a 28% reduction in their rate of mortality and patients with oestrogen receptor negative breast cancer tend to have earlier disease recurrence and reduced survival times. Regarding prostate cancer, only 33% of men with stage 4 metastatic cancer will survive beyond 5 years after diagnosis. Patients with androgen-independent (also known as castrate-independent) prostate cancer have fewer treatment options and metastatic prostate cancer is deemed incurable with a median survival of 6–9 months after its development. The major problem, in terms of successful treatment of cancer, is the development of chemotherapeutic resistance by the cancer cells which results in unopposed metastasis of the cancer and ultimately death of the patient. Therefore, there is a need to identify the mechanisms responsible for the induction of chemotherapeutic resistance and to develop therapeutics that can circumvent or block this and thereby provide an effective means to killing the cancer cell." @default.
- W2016168519 created "2016-06-24" @default.
- W2016168519 creator A5004191810 @default.
- W2016168519 creator A5019808388 @default.
- W2016168519 creator A5023834954 @default.
- W2016168519 creator A5029388712 @default.
- W2016168519 creator A5060561968 @default.
- W2016168519 creator A5064469818 @default.
- W2016168519 date "2012-01-01" @default.
- W2016168519 modified "2023-09-25" @default.
- W2016168519 title "Targeting sphingosine kinase 1 in cancer" @default.
- W2016168519 cites W1969996654 @default.
- W2016168519 cites W1970126428 @default.
- W2016168519 cites W1973573934 @default.
- W2016168519 cites W1983079076 @default.
- W2016168519 cites W1997458456 @default.
- W2016168519 cites W2000678775 @default.
- W2016168519 cites W2015354948 @default.
- W2016168519 cites W2020377899 @default.
- W2016168519 cites W2020730385 @default.
- W2016168519 cites W2021908619 @default.
- W2016168519 cites W2023293937 @default.
- W2016168519 cites W2033562377 @default.
- W2016168519 cites W2045991166 @default.
- W2016168519 cites W2047607345 @default.
- W2016168519 cites W2047734640 @default.
- W2016168519 cites W2051917023 @default.
- W2016168519 cites W2053310582 @default.
- W2016168519 cites W2065410217 @default.
- W2016168519 cites W2072134495 @default.
- W2016168519 cites W2076705867 @default.
- W2016168519 cites W2077609848 @default.
- W2016168519 cites W2078752042 @default.
- W2016168519 cites W2078794107 @default.
- W2016168519 cites W2087924225 @default.
- W2016168519 cites W2089040739 @default.
- W2016168519 cites W2096273281 @default.
- W2016168519 cites W2097202436 @default.
- W2016168519 cites W2101672301 @default.
- W2016168519 cites W2125036060 @default.
- W2016168519 cites W2132805096 @default.
- W2016168519 cites W2135889062 @default.
- W2016168519 cites W2136584723 @default.
- W2016168519 cites W2144464933 @default.
- W2016168519 cites W2151824014 @default.
- W2016168519 cites W2151948261 @default.
- W2016168519 cites W2156263183 @default.
- W2016168519 cites W2156502916 @default.
- W2016168519 cites W2167876561 @default.
- W2016168519 doi "https://doi.org/10.1016/j.advenzreg.2011.07.001" @default.
- W2016168519 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21791223" @default.
- W2016168519 hasPublicationYear "2012" @default.
- W2016168519 type Work @default.
- W2016168519 sameAs 2016168519 @default.
- W2016168519 citedByCount "29" @default.
- W2016168519 countsByYear W20161685192013 @default.
- W2016168519 countsByYear W20161685192014 @default.
- W2016168519 countsByYear W20161685192015 @default.
- W2016168519 countsByYear W20161685192017 @default.
- W2016168519 countsByYear W20161685192018 @default.
- W2016168519 countsByYear W20161685192019 @default.
- W2016168519 countsByYear W20161685192020 @default.
- W2016168519 countsByYear W20161685192022 @default.
- W2016168519 crossrefType "journal-article" @default.
- W2016168519 hasAuthorship W2016168519A5004191810 @default.
- W2016168519 hasAuthorship W2016168519A5019808388 @default.
- W2016168519 hasAuthorship W2016168519A5023834954 @default.
- W2016168519 hasAuthorship W2016168519A5029388712 @default.
- W2016168519 hasAuthorship W2016168519A5060561968 @default.
- W2016168519 hasAuthorship W2016168519A5064469818 @default.
- W2016168519 hasConcept C121608353 @default.
- W2016168519 hasConcept C170493617 @default.
- W2016168519 hasConcept C184235292 @default.
- W2016168519 hasConcept C2776596873 @default.
- W2016168519 hasConcept C2777550365 @default.
- W2016168519 hasConcept C2777700496 @default.
- W2016168519 hasConcept C2778703144 @default.
- W2016168519 hasConcept C502942594 @default.
- W2016168519 hasConcept C54355233 @default.
- W2016168519 hasConcept C55493867 @default.
- W2016168519 hasConcept C70721500 @default.
- W2016168519 hasConcept C86803240 @default.
- W2016168519 hasConcept C95444343 @default.
- W2016168519 hasConceptScore W2016168519C121608353 @default.
- W2016168519 hasConceptScore W2016168519C170493617 @default.
- W2016168519 hasConceptScore W2016168519C184235292 @default.
- W2016168519 hasConceptScore W2016168519C2776596873 @default.
- W2016168519 hasConceptScore W2016168519C2777550365 @default.
- W2016168519 hasConceptScore W2016168519C2777700496 @default.
- W2016168519 hasConceptScore W2016168519C2778703144 @default.
- W2016168519 hasConceptScore W2016168519C502942594 @default.
- W2016168519 hasConceptScore W2016168519C54355233 @default.
- W2016168519 hasConceptScore W2016168519C55493867 @default.
- W2016168519 hasConceptScore W2016168519C70721500 @default.
- W2016168519 hasConceptScore W2016168519C86803240 @default.
- W2016168519 hasConceptScore W2016168519C95444343 @default.
- W2016168519 hasIssue "1" @default.
- W2016168519 hasLocation W20161685191 @default.